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Abstract
Background
The abstraction of data from medical records is a widespread practice in epidemiological re-
search. However, studies using this means of data collection rarely report reliability. Within
the Transition after Childhood Cancer Study (TaCC) which is based on a medical record ab-
straction, we conducted a second independent abstraction of data with the aim to assess a)
intra-rater reliability of one rater at two time points; b) the possible learning effects between
these two time points compared to a gold-standard; and c) inter-rater reliability.
Method
Within the TaCC study we conducted a systematic medical record abstraction in the 9
Swiss clinics with pediatric oncology wards. In a second phase we selected a subsample of
medical records in 3 clinics to conduct a second independent abstraction. We then as-
sessed intra-rater reliability at two time points, the learning effect over time (comparing each
rater at two time-points with a gold-standard) and the inter-rater reliability of a selected num-
ber of variables. We calculated percentage agreement and Cohen’s kappa.
Findings
For the assessment of the intra-rater reliability we included 154 records (80 for rater 1; 74
for rater 2). For the inter-rater reliability we could include 70 records. Intra-rater reliability
was substantial to excellent (Cohen’s kappa 0-6-0.8) with an observed percentage agree-
ment of 75%-95%. In all variables learning effects were observed. Inter-rater reliability was
substantial to excellent (Cohen’s kappa 0.70-0.83) with high agreement ranging from 86%
to 100%.
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Conclusions
Our study showed that data abstracted from medical records are reliable. Investigating
intra-rater and inter-rater reliability can give confidence to draw conclusions from the ab-
stracted data and increase data quality by minimizing systematic errors.
Introduction
The abstraction of data from patients’medical records (MR) is a widespread practice in epide-
miological research, especially in retrospective studies [1–3]. Often, however, the reliability and
internal validity of such data is questionable. This has several reasons. Firstly, data written in
MR have not been produced for research purposes and the adequateness of such data for the
study’s research question needs to be addressed [2]. Secondly, poor reliability due to the poten-
tial intra and inter-rater variance limits internal validity of the results. This is particularly true
for multicenter studies in which several raters are involved, data collection conditions vary,
MR formats differ, data come from different time periods and the data collection leaves room
for interpretation [1]. For this reasons it is important to report reliability of such studies. Fur-
ther, this can help to improve the collection process, to reduce and correct problems or discrep-
ancies, and, later, to gain confidence in the conclusions that will be drawn [4]. Despite the
importance of reporting such measures, only few studies actually do so [2,4–8]. In general,
published retrospective chart reviews which assessed reliability report good reliability levels for
their abstracted data, but we have to remember that publication bias might be a problem in this
type of study with only studies with positive results being published.
The project “Transition after Childhood Cancer (TaCC)” aims to assess the transition from
pediatric to adult care of childhood cancer survivors in Switzerland by collecting data fromMR
in nine clinics and in three language regions. Because no previous study assessed transition
using a systematic chart review for data collection we had to develop and pilot an abstraction
form based on available literature and project aims. For these reasons we found it important to
assess the reliability of collected data by investigating a) intra-rater reliability of two raters at
two time points; b) the possible learning effects over time comparing each rater to a gold-stan-
dard at two time points; and c) inter-rater reliability.
Methods
Ethics statement
Ethics approval was provided through the general cancer registry permission of the Swiss
Childhood Cancer Registry (The Swiss Federal Commission of Experts for Professional Secrecy
in Medical Research) and a non obstat statement was obtained from the ethics committee of
the canton of Bern, stating that no additional ethics permission and no additional informed
consent was necessary. All information regarding individuals was made anonymous to investi-
gators prior to analysis.
Study population
The «Transition after Childhood Cancer (TaCC) » study is a retrospective multicenter study
conducted within the population-based Swiss Childhood Cancer Registry (SCCR). For nearly
four decades the SCCR has been collecting data on all patients diagnosed with leukemia, lym-
phoma, central nervous system (CNS) tumors, malignant solid tumors or Langerhans cell
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histiocytosis before the age of 21 years [9,10]. The TaCC study included a stratified (by diagno-
sis and treating clinic) randomly selected sample of patients registered in the SCCR, who were
diagnosed with childhood cancer at an age between 0 and 15 years, who survived 5 years and
were aged16 years at the time of this study.
Initial data collection for the TaCC study
Within the TaCC study we conducted a systematic MR abstraction at the 9 clinics with pediat-
ric oncology wards throughout Switzerland (all clinics were affiliated to the Swiss Paediatric
Oncology Group). Data collection started in March 2012 and ended in April 2013. For data col-
lection we utilized a standardized abstraction form on hardcopy, which we developed using the
available literature on chart reviews [11]. As suggested by the guidelines, we piloted the abstrac-
tion form in three of the nine clinics, before the actual data abstraction started. We collected
data on the following main categories: frequency of follow-up visits after the age 16 years, med-
ical professionals involved, discharge (patient discharged from pediatric oncology without
being transferred), date of discharge, discharge planned, date of planned discharge, transfer
(patient transferred from pediatric oncology to an adult medical professional), transfer destina-
tion, date of transfer, missed follow-up appointments (the patient did not go to a visit). We dig-
itally photographed all relevant documents as “back up” and saved them on secure servers.
Following data collection, we used Epidata 3.1 to enter our data into a database. All baseline de-
mographic or clinical information were directly extracted from the SCCR database.
Sample for reliability assessment
The number of re-abstractions we carried out was based on the number of medical charts avail-
able containing information about the variables to be extracted as well as on formal sample size
calculations for the kappa statistic [12]. Using alpha and beta error rates of 0.05 and 0.2, respec-
tively, when testing for a statistical difference between moderate (i.e., 0.40) and high (i.e., 0.75)
kappa values, sample size estimates ranged from 77 to 28 when the trait prevalence was varied
between 10% and 50%. Thus, our sample sizes for intra-rater reliability and inter-rater provid-
ed the needed power to detect differences. We selected all medical records that did not have
any missing values in the variables under investigation. We conducted the re-abstraction in the
first three clinics of the same language region.
Re-abstraction
For the re-abstraction we focused exclusively on the most important variables, namely: the var-
iables “still in pediatric follow-up (yes, no)”, “transferred (yes, no)”, “discharged (yes, no)”,
“transfer destination” (general practitioner, adult oncologist, other specialist), and the date var-
iables “date of transfer”, “date of discharge” and “date of next visit in pediatric oncology”
(Table 1).
Medical record raters
Three study raters were chosen to carry out the abstraction in the different clinics based on
their linguistic knowledge (they had to be proficient in all national languages) and on their
level of education. All raters held a degree at the Master level, one in pedagogy/psychology, the
second in social sciences and the third in biology. None of the raters had clinical experience,
which we believed was not necessary for the purpose of this abstraction. One of these three
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raters (Master in Biology) had joined the research team later and was therefore excluded from
the reliability study.
Both raters included in the reliability study were trained prior to data collection for the most
important concepts assessed in the TaCC study. To measure intra-rater reliability the 2 raters
abstracted a selected sample of medical records at two points in time. Both raters did not have
access to the results collected at time 1.
To investigate possible learning effects between time point 1 and time point 2, the project
manager (MEG) also abstracted the data of the same patients. These data were considered the
gold standard and results of the two raters at time point 1 and 2 were than compared against
the gold standard. To assess inter-rater reliability the 2 raters independently abstracted data of
the same study subjects at time point 2.
Statistical analysis
We performed all analyses using Stata 12.0 (StataCorp, College Station, TX). We first calculat-
ed percentage agreement, i.e. the proportion of assessments in which the two observations
agreed, Cohen’s kappa and Prevalence-Adjusted Bias-Adjusted Kappa (PABAK) for all variable
in intra-rater and inter-rater comparison [13]. For the intra-rater reliability analysis we present
results per rater when possible. To assess possible learning effects between point in time 1 and
point in time 2, we calculated the Cohen’s kappa between data collected by each rater at the
two points in time and the data collected by the project manager MEG (gold standard).
Cohen’s Kappa and Adjusted Kappa
Kappa indicates a numeric rating of the degree of agreement between two raters, taking into ac-
count the degree of agreement which would be expected by chance. The calculation of Cohen’s
Table 1. Variables assessed in the re-abstraction.
Variable Description Categories
Transfer This variable is used to assess whether the patient has
been transferred from pediatric oncology to an adult
medical professional.
Yes/No
Discharge This variable is used to assess whether the patient has
been discharged from pediatric oncology without being
referred to another medical professional.
Yes/No
In Follow-up This variable is used to assess whether the patient
had regular follow-up visits in pediatric oncology at the
time of data collection
Yes/No
Transfer destination This variable is used to assess to which adult health
professional the patient has been transferred to.
1.General Practitioner
2. Adult Oncologist
3. Other Specialist
Transfer date Here the day, month and year of transfer had to be
indicated.
dd, mm, yyyy
Discharge date Here the day, month and year of discharge had to be
indicated.
dd, mm, yyyy
Date of next visit in
pediatric oncology
Here the day, month and year of the next visit at
pediatric oncology have to be indicated.
dd, mm, yyyy
The categorical variables represent a more challenging collection than date variables because the
corresponding information had to be found in free text and often necessitated an interpretation.
doi:10.1371/journal.pone.0124290.t001
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kappa is based on the difference between the agreement that is actually present (Pra) and the
agreement obtained by chance alone (Pre) (Formula 1) [14]. Kappa’s values range from 0 to 1
with 0 meaning “less than chance agreement” and 1 “almost perfect agreement”.
k ¼ PrðaÞ  PrðeÞ
1 PrðeÞ ðFormula1Þ
Formula 1, however, does not take into account the bias between observers (the extent of
disagreement) or the distribution of data across the categories that are used (prevalence). The
following example will show how identical agreement can lead to different coefﬁcients of
kappa because of the different prevalence of data across the categories.
In both Tables 2 and 3 there is equal agreement (60 from yes and no: 25+35 and 45+ 15).
However, if we apply Formula 1 to calculate Cohen’s kappa we will end up with different re-
sults (K1 = 0.1304 and K2 = 0.2593). This difference in results occurs because of the different
distribution of data in the 2x2 cells (the so called prevalence) [12].
The interpretation of kappa alone without any indication of prevalence or bias can be im-
precise. To overcome this problem an alternative form of kappa has been proposed which takes
into account both bias and prevalence [15]. This is summarized by the Prevalence-Adjusted
Bias-Adjusted Kappa (PABAK). PABAK gives the proportion of agreement beyond expected
chance agreement regardless of unbalanced data patterns. The interpretation of PABAK is the
same as for kappa. If we consider a 2x2 table like the one in Table 4, PABAK is calculated as in
Formula 2.
PABAK ¼ ðaþ bÞ  ðbþ cÞ
n
ðFormula2Þ
Interpretation of Cohen’s kappa
To interpret our result we used as benchmark the cut-off proposed by Landis and Koch [16] ac-
cording to whom Cohen’s kappas 0.80 represent excellent agreement, coefficients between
0.61 and 0.80 represent substantial agreement, coefficients between 0.41 and 0.61 moderate
agreement and<0.41 fair to poor agreement.
Table 2. Kappa example 1.
R
at
er
2
Rater 1
Yes No
Yes 45 15
No 25 15
doi:10.1371/journal.pone.0124290.t002
Table 3. Kappa example 2.
R
at
er
2
Rater 1
Yes No
Yes 25 35
No 5 35
doi:10.1371/journal.pone.0124290.t003
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Results
Sample
The final analysis included 154 records for the assessment of intra-rater reliability. Of these, 80
had been viewed by rater 1 and 74 by rater 2. Mean time between first (point in time 1) and sec-
ond abstraction (point in time 2) was 7.6 months (SD = 2.2), range (2.1–10.3 months). For the
assessment of inter-rater reliability we included 70 records (Fig 1).
Intra-rater reliability
Overall, all variables assessed had substantial (Cohen’s kappa 0.6) to excellent agreement
(Cohen’s kappa 0.8) with an observed percentage agreement ranging from 75% (date of next
visit in pediatric oncology) to 95% (date of transfer) (Fig 2).
After taking into account prevalence and bias, PABAK was higher for all variables and ran-
ged from 0.64 to 0.81 than the unadjusted kappa values (Table 5; Fig 3).
The variable “in follow-up” had the highest Cohen’s kappa (k = 0.76), while transfer and
discharge had the lowest (k = 0.62 and k = 0.63) (Fig 2).
Table 4. Example for the Prevalence-Adjusted Bias-Adjusted Kappa (PABAK).
R
at
er
2
Rater 1
Yes No
Yes a b
No c d
doi:10.1371/journal.pone.0124290.t004
Fig 1. Flow chart of sample selection for reliability assessment. Fig 1 shows the flow chart of our study
population starting from those eligible to those included in the analysis.
doi:10.1371/journal.pone.0124290.g001
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Date variables had Cohen’s kappas (k) above 0.9 except “date of next visit” were k was 0.7.
When looking at the results stratified by the two raters, we could see that Cohen’s kappas
were consistently higher for rater 1 than for rater 2. Especially for the variables transfer and dis-
charge rater 2 had Cohen’s kappas< 0.5 (Table 5).
Learning effects
When looking at learning effects between point in time 1 and point in time 2 against the data
collected by the project manager MEG we can see that kappa’s values greatly improved for
both raters (all ps<0.001) (Fig 4).
Inter-rater reliability
For the variables transfer, discharge, in follow up and transfer destination the observed agree-
ment was high ranging from 86% to 91% (Table 6).
Cohen’s kappas reached substantial or excellent agreement ranging from 0.70 (discharge) to
0.83 (transfer destination) (Table 6; Fig 2). After adjusting for prevalence and bias, the true pro-
portion of agreement (PABAK) was higher for all variables and ranged from 0.71 to 0.84
(Table 6). Among the categorical variables, “in follow-up” had the highest Cohen’s kappa
(k = 0.76), while transfer and discharge had the lowest (k = 0.62 and k = 0.63). Agreement and
kappa were perfect (100%; k = 1) for the three date variables assessed.
Discussion
Results of our study showed that for both intra-rater and inter-rater we had substantial to ex-
cellent agreement. As expected, the variables for which no interpretation was necessary (e.g.
date variables), higher and often perfect agreement was present. We found that one rater
Fig 2. Kappa values and their interpretation for intra-rater and inter-rater reliability. Fig 2 shows the values of kappa for intra-rater (dark blue) and for
inter-rater (light blue) reliability with their confidence intervals T for each variable under investigation.
doi:10.1371/journal.pone.0124290.g002
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consistently had lower intra-rater agreement, but further analysis showed an improvement of
judgment between point in time 1 and point in time 2 for both raters when compared to the
chosen gold standard. Unexpectedly, Cohen’s kappas were higher for inter-rater reliability
than for intra-rater reliability.
Strengths and Limitations
This is the first study assessing transition from pediatric to adult care with medical records
which tested for intra-rater and inter-rater reliability of the collected data. Because the variables
assessed were not always easy to find in the medical records nor easy to rate, these results give
us the confidence needed to interpret the data collected. Because data collection was still ongo-
ing, assessing reliability also gave us the opportunity to identify possible problems related to
the rater’s comprehension and intervene in case we had the impression systematic errors were
occurring. For data which we had already collected we performed a double control to make
sure the possible mistakes of the first phase could be corrected.
The study has however limitations. Firstly, the sample size did not allow detection of inter-
hospital differences or differences between different types of medical records (i.e. paper versos
micro film) or archiving periods, which could possibly explain some of the rater variability. We
also included three clinics only, while the whole study was carried out in a total of nine, in
three different language regions. Caution is therefore needed in the generalization of results. In
our study we only looked at documents from pediatric oncology and, even though they contain
correspondence with the other specialists involved in follow-up, it was often difficult to fully
understand the patients’medical history. This was further aggravated by the fact, that none of
Table 5. Intra-rater reliability.
Variable Agreement kappa 95% CI PABAK
Transfer 82% 0.62 0.43–0.79 0.64
Rater 1 85% 0.67 0.43–0.91 0.73
Rater 2 77% 0.48 0.20–0.73 0.58
Discharge 84% 0.63 0.47–0.79 0.78
Rater 1 90% 0.77 0.57–0.98 0.79
Rater 2 75% 0.45 0.22–0.75 0.47
In Follow-up 88% 0.76 0.51–0.87 0.81
Rater 1 90% 0.77 0.64–0.91 0.80
Rater 2 86% 0.58 0.49–0.67 0.71
Transfer destination 88% 0.69 0.64–0.88 n.a.d
Rater 1 91% 0.74 0.62–0.86 n.a.d
Rater 2 82% 0.51 0.40–0.62 n.a.d
Date of transfer 95% 0.94 0.89–1.00 n.a.d
Rater 1 91% 0.89 0.74–1.00 n.a.
Rater 2 100% 1.00 - n.a.
Date of discharge 93% 0.93 0.81–0.95 n.a.d
Rater 1 100% 1.00 - n.a.d
Rater 2 86% 0.85 0.66–0.91 n.a.d
Date of next visit 75% 0.70 0.50–0.82 n.a.d
Rater 1 78% 0.70 0.45–0.82 n.a.d
Rater 2 67% 0.50 0.40–0.81 n.a.d
Abbreviations: CI, Conﬁdence Interval; kappa, Cohen’s kappa; n.a., not applicable; PABAK, Prevalence and Bias Adjusted Kappa.
doi:10.1371/journal.pone.0124290.t005
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Fig 3. Kappa values and Prevalence-adjusted Bias-adjusted kappa values for intra-rater (a) and inter-rater reliability (b). Fig 3a and 3b show the
values of kappa compared to the the values obtained by calculating the Prevalence-adjusted Bias-adjusted kappa for intra-rater reliability (a) and inter-rater
reliability (b).
doi:10.1371/journal.pone.0124290.g003
Reliability of a Medical Record Abstraction Study
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the raters had expertise in clinical practice and was familiar with the local documentation sys-
tems. Finally, kappa has known limitations which we tried to overcome by reporting the preva-
lence-adjusted bias-adjusted kappa as proposed by several authors [12,15].
Fig 4. Learning effect of the two raters at two points in time compared with the abstraction of the project manager. Fig 4a and 4b show the
comparison of the abstraction at two points in time of rater 1 (a) and rater 2 (b) compared to the chosen golden standard (abstraction of the project manager).
doi:10.1371/journal.pone.0124290.g004
Reliability of a Medical Record Abstraction Study
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Comparison with other studies
None of the studies that looked at assessing transition from pediatric to adult care did investi-
gate reliability of the abstracted data. We found several studies assessing mostly inter-rater reli-
ability of diagnostic tests (screening and detection of adverse events) which were not directly
comparable to ours. Two studies [4, 8] were more similar in methodology and scope to ours: in
the first one the authors found that agreement was poorer for variables for which a degree of
interpretability was needed (judgment data), while it was higher for data such as demographic
or numeric characteristics [8]. The same was found in the second multicenter study using med-
ical record abstraction in a study on community-based asthma care program [4]. In this study
they found that the multicenter abstraction of data from medical records is reliable and conclu-
sions could be drawn from the results. They found an overall Cohen’s kappa for intra-rater reli-
ability of 0.81 (excellent) and an overall Cohen’s kappa of 0.75 (substantial) in the inter-rater
analysis.
Interpretation of results
Even though we could not reach perfection in the abstraction of the data, our results are reas-
suring and showed satisfactory levels of agreement. Further, the raters’ improvement in judg-
ment between time 1 and time 2, probably due to a learning effect, allows to assume that the
abstraction in the remaining 6 clinics not included in the present study, is of at least similar or
higher quality and reliability. As it was expected, agreement was higher for non-judgment vari-
ables such as dates. Such information mostly does not require interpretation. Other data such
as the variables “transfer” or “transfer destination” were to be looked for in free texts such as
letters or medical reports and it often required a different degree of attention and interpreta-
tion. Indeed, data abstraction was difficult because in the pediatric oncology setting several
other specialists are often involved in the follow-up of patients (e.g. neurologists, endocrinolo-
gists). Documents found were often from various specialists and the raters had to decide
whether, for example, a patient was transferred from pediatric oncology or whether the patient
was actually transferred from another specialist. A patient could namely still be in follow-up in
pediatric oncology, but might have been transferred from pediatric endocrinology to adult en-
docrinology. This was often a source of confusion when abstracting data.
In contrast to other studies [4,7], we found higher inter-rater reliability than intra-rater. Be-
cause inter-rater reliability was assessed at point in time 2 only this higher reliability may be
due to the learning effect we could show.
Table 6. Inter-rater reliability.
Variable Agreement kappa 95% CI PABAK
Transfer 88% 0.73 0.68–0.78 0.75
Discharge 86% 0.70 0.62–0.78 0.71
In Follow-up 91% 0.74 0.64–0.84 0.81
Transfer destination 89% 0.83 0.71–0.88 n.a.d
Date of transfer 100% 1.00 - n.a.d
Date of discharge 100% 1.00 - n.a.d
Date of next visit 100% 1.00 - n.a.d
Abbreviations: CI, Conﬁdence Interval; kappa, Cohen’s kappa; n.a., not applicable; PABAK, Prevalence and Bias Adjusted Kappa.
doi:10.1371/journal.pone.0124290.t006
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Implications for practice
Despite the well-known limitations of retrospective studies using MR or other secondary data,
an increasing number of studies have shown that such an approach can produce reliable results
if the procedure is consistent and standardized, and if raters are appropriately trained. It would
be interesting to investigate whether the archives’ organization, the documents’ age and the for-
mat of such documents (e.g. microfilm, electronic, hardcopy) influence the quality of the re-
trieved data. Finally, such an analysis could help detect possible problems such as rater’s
comprehension difficulties or discrepancies and improve the overall quality of retrospective
studies.
Conclusion
Our study showed that despite several limitations attributed to data abstracted fromMR, our
data seems to be reliable. Thanks to the assessment of learning effects, systematic errors could
be corrected and general data quality improved. With good training and a standardized proce-
dure good reliability can be achieved.
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